About Us
|
Our Doctors |
| |
Dr. Patrizio Caturegli is an Assistant Professor of Pathology and Endocrinology at Johns Hopkins. He graduated in 1980 from “La Querce College” in Florence, Italy (BA, Letters), and from the University of Pisa Medical School in 1987. He then completed a residency in Endocrinology also in Pisa (Italy), where he was Board-certified in 1992. Since 1993, Dr. Caturegli has been at Johns Hopkins. Here he completed a 3-year fellowship in immunology with Dr. Noel Rose and then a Residency in Pathology (certified by the American Board of Pathology in 1999). Since July 1999 he is a faculty member in the School of Medicine. His research focuses on the autoimmune diseases of the endocrine glands.
top
|
|
| |
Dr. Angelika Gutenberg graduated from Medical School at
Georg-August-University, Goettingen, Germany, in 2003. She completed an
eighteen month research fellowship at the Department of Neuropathology
at Goettingen University Hospital, concentrating on primary
hypophysitis and characterizing the autoimmunologic mechanism leading
to pituitary infiltration in humans. Since June 2004 she has started
her residency at the Neurosurgical Department. Her research, next to
molecular genetics of primary brain tumors, focuses on establishing an
experimental model of autoimmune hypohysitis in rats. Dr. Gutenberg is
supported by the Research program of the Faculty of Medicine,
Georg-August-Universitiy Goettingen. She has been seeing hypophysitis patients before and after transphenoidal operation.
top
|
|
| |
Dr. Craig Newschaffer is an Associate Professor in the Epidemiology
Department of the Johns Hopkins School of Public Health. He directs
the Johns Hopkins Center for Autism and Developmental Disabilities
Epidemiology. Dr. Newschaffer has a range of experience with disease
surveillance and registries. Currently, he is developing the first
population-based surveillance system for autism spectrum disorders. He
has also been involved in a number of cancer-registry based research
projects, ranging from molecular epidemiology to outcome research.
top
|
|
| |
Dr. Peter Burger is a Professor of Pathology, Neurosurgery and Oncology. He
is one of the world's leading authorities in the interpretation of
surgical specimens of brain and spinal cord tumors in children and
adults. He is co-author of the Surgical Pathology of the Nervous
System and its Coverings (now in the 4th edition), AFIP Atlas of Tumor
Pathology, and Tumors of the Central Nervous System. He has over 20
years experience and more than 200 publications. He is a member of the
editorial boards of two leading peer-review journals and participates
in numerous scientific committees, including New Approaches to Brain
Tumor Therapy Consortium and World Health Organization Histological
Typing of Tumors of the Central Nervous System.
top
|
|
| |
Dr. Martin Pomper was born in Chicago, Illinois and attended college at the University of Illinois at Urbana-Champaign, majoring in biochemistry and chemistry. Also at Illinois, in the context of the Medical Scholars Program, he earned M.D. and Ph.D. degrees, the latter in organic chemistry. All of his postgraduate medical training was undertaken at the Johns Hopkins University School of Medicine, which included an internship in medicine (Osler Service), residencies in radiology and nuclear medicine, and a neuroradiology fellowship. He is currently an associate professor in the Neuroradiology Division of the Department of Radiology. His research interests involve molecular imaging, particularly of central nervous system processes and cancer.
Dr. Pomper is also the director of the Small Animal Imaging Resource Program (SAIRP) at Johns Hopkins and Deputy Director of the In Vivo Cellular and Molecular Imaging Center (ICMIC). Specific research projects in central nervous system imaging include:
(a) using magnetic resonance spectroscopy (MRS) to uncover brain metabolic correlates of AIDS dementia,
(b) using positron emission tomography (PET) to study molecular (neurotransmitter) and cellular abnormalities in patients with AIDS dementia, and
(c) the development of new radiopharmaceuticals for imaging nicotinic and glutamatergic neurotransmission.
In oncology, advanced magnetic resonance imaging (MRI) techniques, such as sodium imaging, diffusion tensor imaging, and MRS are being used to study brain tumors. In addition, PET agents are being pursued to study prostate cancer, angiogenesis and to study the pharmacokinetics of chemotherapeutic agents in vivo.
From a clinical standpoint, his interests lie in central nervous system vasculitis and brain tumor imaging, serving as a member of the Johns Hopkins Vasculitis Center and of a consortium to develop New Approaches to Brain Tumor Therapy (NABTT). In collaboration with the Department of Neurosurgery, he is heading up a new initiative to develop an imaging center dedicated to the characterization of brain tumors.
top
|
|
| |
Dr.
Alessandro Olivi is the Director of the Department of Neurosurgery at
the Johns Hopkins Bayview Medical Center, Director of Neurosurgical Oncology,
and Professor of Neurosurgery at the Johns Hopkins University School of
Medicine.
His practice specializes in the surgical treatment of primary and metastatic
tumors of the brain and spinal cord. He performs microsurgical operations
on tumors of the skull base such as acoustic neuromas and meningiomas
and vascular lesions. He also performs a large number of stereotactic
diagnostic procedures.
As the Director of the Division of Neurosurgical Oncology, Dr. Olivi is
primarily involved in the multi-disiplinary approach of patients affected
by brain tumors in close collaboration with the Departments of Medical
Oncology, Radiation Oncology, Neurology and Radiology. He coordinates
the most suitable management of patients with newly diagnosed or recurrent
brain tumors.
Dr. Olivi is also is actively involved in clinical and experimental research
for the treatment of brain tumors. He conducts a number of clinical protocols
and directs experimental projects of interstitial chemotherapy and local
immunotherapy.
Dr. Olivi conducts a Neurosurgical clinic on Tuesdays from 8:30 AM to
2:00 PM at the Johns Hopkins Hospital. Appointments may be scheduled by
calling his secretary Rose Calini at 410-955-0703. He also conducts a
Neurosurgical Clinic at the Johns Hopkins Bayview Medical Center on alternate
Mondays from 8:00 AM to 5:00 PM. Appointments at this site may be scheduled
by calling his secretary at 410-550-0465.
top
|
|
| |
Dr. Noel R. Rose is a Professor in the Department of Pathology (School of Medicine) and in the W. Henry Feinstone Department of Molecular Microbiology and Immunology (School of Public Health), with joint appointments in the Departments of Medicine and of Environmental Health Sciences. His pioneering studies on autoimmune thyroiditis in the 1950's helped to initiate the modern era of research on autoimmune disease. He and his colleagues have continued to contribute to our understanding of autoimmunity, including the first demonstration of the genetic factors responsible for predisposition to autoimmune disease in animals and more recent investigations on the influence of infection and environmental agents in the initiation of autoimmune disease in genetically predisposed animals.
top
|
|
| |
Dr. Giovanni Pinna received a M.D. degree from the University of Cagliari, Italy in 1998. He then completed 3 years of internship in internal
medicine and is a fourth year resident in his residency training
in Endocrinology and Metabolism. He arrived at Johns Hopkins University
in January 2002 as a postdoctoral fellow in Dr. Caturegli's laboratory.
Dr Pinna's main interests are the autoimmune diseases which affect endocrine glands.
For this reson he started my study in Autoimmune Hypophysitis. Dr. Pinna plans to
develop an animal model of this disease, with the goal to understand either
the autoimmune mechanism of the disease or how the autoimmune damage
can affect the function of the pituitary gland.
top
|
|
| |
Dr. Stefano Mariotti is a Professor of Endocrinology at the Medical
School of the University of Cagliari (Italy). Since 1994 he is also
the Director of the Postgraduate School of Endocrinology in Cagliari.
He trained academically at the University of Pisa (1972-1994) and
abroad: at the Thyroid Study Unit, Department of Medicine of the
University of Chicago (1978-79), at the Institut de Recherches
Interdisciplinaires en Biologie Humaine et Nucleaire in Bruxelles (1987
and 1989), and at the Laboratories des Hormones Protéique, Faculté de
Medicine in Marseille (1989).
Dr. Mariotti has more than 20 years of experience in endocrine diseases
and more than 100 publications. His clinical and research interests
focus on diseases of the thyroid and pituitary glands, with special
regard to autoimmune thyroid diseases, epidemiology of endemic goiter,
and interactions between aging and the endocrine system. Recently, he
is involved in a multi-center research project aimed to define the
clinical spectrum and autoantibody profile of patients with autoimmune
diseases of the pituitary gland.
top
|
|
|
|
